NAMD Letter to House Leadership Addresses Substance Use Disorder Privacy Requirements

NAMD sent a letter to House of Representatives leadership on the need to address the privacy laws governing substance use disorder information as part of opioid legislation under consideration in the House. The letter underscores the need to amend the privacy laws of 42 CFR Part 2 to fully address the opioid crisis, and ensure individuals with substance use disorders receive integrated care delivery and benefit from person-centered models built on the foundation of integration.

Read full letter.

 

Comments are closed.